Take Your Trading To The Next Level. Get Started Here!

Moderna says flu vaccine showed promising results in phase three trial, paving path to approval

September 13, 2023 Comments Off

Moderna compared the flu vaccine, dubbed mRNA-1010, to a currently approved seasonal flu vaccine from GlaxoSmithKline called Fluarix.